Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary

Human Pathology

Volumn 43, Issue 6, 2012, Pages 904-910

  Sekiya, Ryuichiro ^a   Kajiyama, Hiroaki ^a   Sakai, Kotaro ^b   Umezu, Tomokazu ^a   Mizuno, Mika ^a   Shibata, Kiyosumi ^a   Yamamoto, Eiko ^a   Fujiwara, Sawako ^a   Nagasaka, Tetsuro ^c   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Daido Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Clear cell carcinoma (CCC); CXCR4; Immunohistochemistry; Metastasis; Prognosis

Indexed keywords

CA 125 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; PARAFFIN; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 84861191031     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.08.002     Document Type: Article

References (21)

1. S.F. Serov, R.E. Scully, and L.H. Sobin International histological classification of tumors. No 9. Histologic typing of ovarian tumors 1973 World Health Organization Geneva
2. P.B.P. Rusell Surgical pathology of the ovaries 1989 Churchill Livingstone New Yolk
3. A.W. Kennedy, C.V. Biscotti, W.R. Hart, and K.D. Webster Ovarian clear cell adenocarcinoma Gynecol Oncol 32 1989 342 349 (Pubitemid 19074926)
4. T. Sugiyama, T. Kamura, and J. Kigawa Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2000 2584 2589 (Pubitemid 30331967)
5. B.A. Goff, R. Sainz de la Cuesta, and H.G. Muntz Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease Gynecol Oncol 60 1996 412 417 (Pubitemid 26077628)
6. M.E. O'Brien, J.B. Schofield, S. Tan, I. Fryatt, C. Fisher, and E. Wiltshaw Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages Gynecol Oncol 49 1993 250 254 (Pubitemid 23170001)
7. K. Behbakht, T.C. Randall, I. Benjamin, M.A. Morgan, S. King, and S.C. Rubin Clinical characteristics of clear cell carcinoma of the ovary Gynecol Oncol 70 1998 255 258 (Pubitemid 28430939)
8. D. Pectasides, G. Fountzilas, and G. Aravantinos Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience Gynecol Oncol 102 2006 285 291 (Pubitemid 44041640)
9. S. Barbero, R. Bonavia, and A. Bajetto Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt Cancer Res 63 2003 1969 1974 (Pubitemid 36460865)
10. J. Libura, J. Drukala, and M. Majka CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion Blood 100 2002 2597 2606
11. T. Murakami, W. Maki, and A.R. Cardones Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells Cancer Res 62 2002 7328 7334 (Pubitemid 36025256)
12. C.J. Scotton, J.L. Wilson, and K. Scott Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer Cancer Res 62 2002 5930 5938 (Pubitemid 35204756)
13. R.J. Phillips, M.D. Burdick, M. Lutz, J.A. Belperio, M.P. Keane, and R.M. Strieter The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases Am J Respir Crit Care Med 167 2003 1676 1686 (Pubitemid 36760683)
14. C.J. Scotton, J.L. Wilson, D. Milliken, G. Stamp, and F.R. Balkwill Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61 2001 4961 4965 (Pubitemid 32681518)
15. Miyanishi N, Suzuki Y, Simizu S, Kuwabara Y, Banno K, Umezawa K. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem Biophys Res Commun 403:154-9.
16. H. Kajiyama, K. Shibata, M. Terauchi, K. Ino, A. Nawa, and F. Kikkawa Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma Int J Cancer 122 2008 91 99 (Pubitemid 350209982)
17. E.E. Khin, F. Kikkawa, and K. Ino Neutral endopeptidase/CD10 expression in the stroma of epithelial ovarian carcinoma Int J Gynecol Pathol 22 2003 175 180 (Pubitemid 36348792)
18. J.K. Chan, D. Teoh, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers Gynecol Oncol 109 2008 370 376
19. Y.P. Jiang, X.H. Wu, B. Shi, W.X. Wu, and G.R. Yin Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression Gynecol Oncol 103 2006 226 233 (Pubitemid 44374693)
20. Singh S, Srivastava SK, Bhardwaj A, Owen LB, Singh AP. CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. Br J Cancer 103:1671-9.
21. Dessein AF, Stechly L, Jonckheere N, et al. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70:4644-54.